AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32429917 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy food nudges (e.g., product placement or promotion)
Number of subjects: 1485
Study 32429917 — intervention group
Group type: EXPERIMENTAL
Intervention: Nudges and pricing strategies (taxing unhealthy foods and subsidizing healthy foods)
Number of subjects: 1485
Study 32429917 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile PA app
Number of subjects: 1485
Study 32429917 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1485
Study 35170079 — intervention group
Group type: EXPERIMENTAL
Intervention: Confusion Assessment Method (CAM)
Number of subjects: 200
Study 35170079 — intervention group
Group type: EXPERIMENTAL
Intervention: Consensus panel diagnosis
Number of subjects: 200
Study 34034821 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Intervention (RI) group - given an appointment at the clinic within 2 days and accompanied to their first appointment.
Number of subjects: 106
Study 34034821 — intervention group
Group type: COMPARATOR
Intervention: Delayed Intervention (DI) group - given contact information for a nearby addiction medicine clinic.
Number of subjects: 106
Study 34034821 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Intervention (RI) group
Number of subjects: 106
Study 34034821 — intervention group
Group type: COMPARATOR
Intervention: Delayed Intervention (DI) group
Number of subjects: 106
Study 36181412 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment plus FMT therapy
Number of subjects: 0
Study 36181412 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 0
Study 36181412 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment plus FMT therapy with 3 administrations
Number of subjects: 0
Study 36181412 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment plus FMT therapy with 6 administrations
Number of subjects: 0
Study 34120649 — intervention group
Group type: EXPERIMENTAL
Intervention: CFL-TB (mobile health intervention using interactive voice response technology)
Number of subjects: 274
Study 34120649 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 274
Study 32111579 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the left PFC (1.5 mA, 5-cm x 5-cm electrodes) with concurrent cathodal tDCS over the right PFC during emotion regulation task.
Number of subjects: 20
Study 32111579 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS during emotion regulation task.
Number of subjects: 20
Study 33256496 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical cannabis
Number of subjects: 0
Study 33256496 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 32209630 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 180
Study 32209630 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 180
Study 32209630 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 32209630 — intervention group
Group type: COMPARATOR
Intervention: Mirtazapine, Ondansetron, Placebo
Number of subjects: 180
Study 35240345 — intervention group
Group type: EXPERIMENTAL
Intervention: Informative video intervention (4-minute video detailing cesarean delivery process)
Number of subjects: 132
Study 35240345 — intervention group
Group type: COMPARATOR
Intervention: Control group (no video)
Number of subjects: 132
Study 35240345 — intervention group
Group type: EXPERIMENTAL
Intervention: Informative video intervention
Number of subjects: 132
Study 32312759 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 IU vitamin E (as alpha‐tocopheryl acetate; ATA) daily in VEAPS
Number of subjects: 254
Study 32312759 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 IU ATA daily in ATBC
Number of subjects: 254
Study 32312759 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose vitamin E in VEAPS
Number of subjects: 254
Study 32312759 — intervention group
Group type: COMPARATOR
Intervention: Placebo in VEAPS
Number of subjects: 254
Study 32312759 — intervention group
Group type: COMPARATOR
Intervention: Placebo in ATBC
Number of subjects: 254
Study 35801770 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone finger cap
Number of subjects: 11
Study 35801770 — intervention group
Group type: COMPARATOR
Intervention: Film dressing
Number of subjects: 11
Study 34078591 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (0.2 mg/kg immediately after the surgical procedure, and on day 1)
Number of subjects: 1222
Study 34078591 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1222
Study 34078591 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 1222
Study 35477363 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-printed heart model used for simulated preoperative surgery
Number of subjects: 46
Study 35477363 — intervention group
Group type: COMPARATOR
Intervention: Morrow operation without simulated preoperative surgery
Number of subjects: 46
Study 33165964 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa
Number of subjects: 35
Study 33165964 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine agonist
Number of subjects: 35
Study 36418131 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinically assisted hydration (CAH) - parenteral fluids (dextrose saline 4% dextrose, 0.18% sodium chloride)
Number of subjects: 1600
Study 33822650 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified clinical pharmacological/pharmaceutical care (medication management and structured patient counseling) over 12 weeks
Number of subjects: 202
Study 33822650 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 202
Study 33822650 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified clinical pharmacological/pharmaceutical care (intervention group)
Number of subjects: 202
Study 33942777 — intervention group
Group type: EXPERIMENTAL
Intervention: ropivacaine + dexmedetomidine (1 μg/kg)
Number of subjects: 138
Study 33942777 — intervention group
Group type: EXPERIMENTAL
Intervention: ropivacaine + fentanyl (1 μg/kg)
Number of subjects: 138
Study 33942777 — intervention group
Group type: EXPERIMENTAL
Intervention: ropivacaine (40 mL/0.5%)
Number of subjects: 138
Study 32169254 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular alveolar recruitment
Number of subjects: 73
Study 32169254 — intervention group
Group type: COMPARATOR
Intervention: Standardised care
Number of subjects: 73
Study 35384692 — intervention group
Group type: EXPERIMENTAL
Intervention: cART (zidovudine, nevirapine, lamivudine)
Number of subjects: 49
Study 35384692 — intervention group
Group type: COMPARATOR
Intervention: No ART
Number of subjects: 49
Study 35384692 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic use
Number of subjects: 49
Study 34606319 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic anticoagulation
Number of subjects: 0
Study 34606319 — intervention group
Group type: COMPARATOR
Intervention: Prophylactic anticoagulation
Number of subjects: 0
Study 32794396 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry dentin
Number of subjects: 45
Study 32794396 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet dentin
Number of subjects: 45
Study 32794396 — intervention group
Group type: COMPARATOR
Intervention: Both groups (dry and wet dentin)
Number of subjects: 45
Study 35078280 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative exercise rehabilitation training for two weeks
Number of subjects: 74
Study 32855073 — intervention group
Group type: EXPERIMENTAL
Intervention: Scapular Movement Training
Number of subjects: 64
Study 32855073 — intervention group
Group type: COMPARATOR
Intervention: Standardized Exercises
Number of subjects: 64
Study 35833346 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct-to-patient telegenetics
Number of subjects: 56
Study 35833346 — intervention group
Group type: COMPARATOR
Intervention: Standard care (telephone/in-person)
Number of subjects: 56
Study 33826591 — intervention group
Group type: EXPERIMENTAL
Intervention: Mazor robotic-guidance (RG)
Number of subjects: 485
Study 33826591 — intervention group
Group type: COMPARATOR
Intervention: Fluoro-guidance (FG)
Number of subjects: 485
Study 35883122 — intervention group
Group type: EXPERIMENTAL
Intervention: High kinesiophobia (TSK > 37)
Number of subjects: 49
Study 35883122 — intervention group
Group type: COMPARATOR
Intervention: Low kinesiophobia (TSK ≤ 37)
Number of subjects: 49
Study 32992531 — intervention group
Group type: EXPERIMENTAL
Intervention: Gerontogymnastics program for 12 weeks
Number of subjects: 216
Study 35366839 — intervention group
Group type: EXPERIMENTAL
Intervention: Allied health first-contact model
Number of subjects: 56
Study 35366839 — intervention group
Group type: COMPARATOR
Intervention: Medical first-contact model
Number of subjects: 56
Study 33404504 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactively offered online and telephone support services for fruit and vegetables
Number of subjects: 551
Study 33404504 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactively offered online and telephone support services for physical activity
Number of subjects: 551
Study 33404504 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactively offered online and telephone support services for smoking
Number of subjects: 551
Study 33404504 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactively offered online and telephone support services for alcohol use
Number of subjects: 551
Study 33404504 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactively offered online and telephone support services for at least two health behaviors
Number of subjects: 551
Study 32928528 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol detoxification (3-week stay in detoxification ward)
Number of subjects: 20
Study 32928528 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy individuals)
Number of subjects: 20
Study 35023868 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-thickness cartilage strip, incomplete cutting technique
Number of subjects: 63
Study 33168838 — intervention group
Group type: EXPERIMENTAL
Intervention: Amylase quantification in the terminal ileum; daily analysis of ileostomy effluent for the first 5 post-operative days.
Number of subjects: 11
Study 35166728 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological interventions
Number of subjects: 200
Study 35166728 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine care + Psychological interventions
Number of subjects: 200
Study 35166728 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 200
Study 33039302 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive rehabilitation (n=7)
Number of subjects: 15
Study 33039302 — intervention group
Group type: COMPARATOR
Intervention: Standard care physiotherapy (n=8)
Number of subjects: 15
Study 35142924 — intervention group
Group type: EXPERIMENTAL
Intervention: Monolithic zirconia FPD (Zenostar T, Wieland Dental)
Number of subjects: 60
Study 35142924 — intervention group
Group type: COMPARATOR
Intervention: Veneered zirconia FPD (IPS e.max ZirCAD, Ivoclar Vivadent)
Number of subjects: 60
Study 34348529 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher genetically predicted IL-1 receptor antagonist (IL-1Ra)
Number of subjects: 15
Study 34348529 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher total IL-18 binding protein (IL-18BP)
Number of subjects: 15
Study 34348529 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher IL-1α
Number of subjects: 15
Study 34348529 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher IL-1R1
Number of subjects: 15
Study 35477986 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromechanical gait training (30 min/day, 5 days/week for 4 weeks)
Number of subjects: 144
Study 35477986 — intervention group
Group type: COMPARATOR
Intervention: Conventional gait training (physical therapist-assisted, 30 min/day, 5 days/week for 4 weeks)
Number of subjects: 144
Study 35477986 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromechanical gait training
Number of subjects: 144
Study 35477986 — intervention group
Group type: COMPARATOR
Intervention: Conventional gait training
Number of subjects: 144
Study 35477986 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromechanical gait training and Conventional gait training
Number of subjects: 144
Study 33858355 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled Multiple Imputation (MI)
Number of subjects: 118
Study 33858355 — intervention group
Group type: COMPARATOR
Intervention: Missing-at-random MI
Number of subjects: 118
Study 33858355 — intervention group
Group type: COMPARATOR
Intervention: Controlled MI
Number of subjects: 118
Study 34883506 — intervention group
Group type: EXPERIMENTAL
Intervention: Clofarabine (CLO) added to induction and consolidation treatment
Number of subjects: 340
Study 36136773 — intervention group
Group type: EXPERIMENTAL
Intervention: Resilience training (Henderson and Milstein's resilience training package)
Number of subjects: 30
Study 33745505 — intervention group
Group type: EXPERIMENTAL
Intervention: Tongue-Stabilizing Device (TSD) therapy
Number of subjects: 39
Study 33745505 — intervention group
Group type: COMPARATOR
Intervention: Mandibular Advancement Device (MAD) therapy
Number of subjects: 39
Study 33051254 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-lung ventilation (OLV) with recruitment maneuvers (RM) using plateau pressures of 50-60 cmH2O
Number of subjects: 0
Study 615918947 — intervention group
Group type: EXPERIMENTAL
Intervention: EDOF1 contact lenses (n=15)
Number of subjects: 52
Study 615918947 — intervention group
Group type: EXPERIMENTAL
Intervention: EDOF2 contact lenses (n=21)
Number of subjects: 52
Study 615918947 — intervention group
Group type: COMPARATOR
Intervention: SV contact lenses (n=16)
Number of subjects: 52
Study 35442223 — intervention group
Group type: EXPERIMENTAL
Intervention: Protease inhibitor-based regimen
Number of subjects: 213
Study 35442223 — intervention group
Group type: COMPARATOR
Intervention: NNRTI-based regimen
Number of subjects: 213
Study 33772746 — intervention group
Group type: EXPERIMENTAL
Intervention: 131I therapy for low-risk DTC patients
Number of subjects: 135
Study 33772746 — intervention group
Group type: EXPERIMENTAL
Intervention: 131I therapy for low-risk papillary thyroid microcarcinomas
Number of subjects: 135
Study 33772746 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial 131I activity for low-risk DTC patients
Number of subjects: 135
Study 33772746 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial 131I activity for intermediate-risk DTC patients
Number of subjects: 135
Study 33772746 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial 131I activity for high-risk DTC patients
Number of subjects: 135
Study 32228627 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid weight loss (RWL) phase (3 days)
Number of subjects: 18
Study 32228627 — intervention group
Group type: COMPARATOR
Intervention: Exercise-only phase (4 days)
Number of subjects: 18
Study 35904252 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright white light (BWL)
Number of subjects: 47
Study 35904252 — intervention group
Group type: COMPARATOR
Intervention: Dim red light (DRL)
Number of subjects: 47
Study 33687578 — intervention group
Group type: EXPERIMENTAL
Intervention: Low PRO-C2 levels
Number of subjects: 253
Study 33687578 — intervention group
Group type: COMPARATOR
Intervention: sCT treatment
Number of subjects: 253
Study 35616795 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-laryngoscope-guided insertion
Number of subjects: 100
Study 35616795 — intervention group
Group type: COMPARATOR
Intervention: Blind insertion
Number of subjects: 100
Study 34256800 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate combined with prednisone
Number of subjects: 347
Study 34256800 — intervention group
Group type: EXPERIMENTAL
Intervention: Certolizumab‐pegol
Number of subjects: 347
Study 34256800 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 347
Study 34256800 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 347
Study 34256800 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 347
Study 33065307 — intervention group
Group type: EXPERIMENTAL
Intervention: Second forward view (SFV) examination of the right colon
Number of subjects: 1011
Study 33065307 — intervention group
Group type: COMPARATOR
Intervention: Standard withdrawal colonoscopy (SWC) examination
Number of subjects: 1011
Study 33065307 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 1011
Study 33598759 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate
Number of subjects: 15
Study 33598759 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 15
Study 33598759 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 32437568 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedometer-based intervention with weekly step goals
Number of subjects: 30
Study 34610460 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents of children with obesity
Number of subjects: 1862
Study 34610460 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents with obesity
Number of subjects: 1862
Study 33588142 — intervention group
Group type: EXPERIMENTAL
Intervention: WTE incinerator activity (after 3 years)
Number of subjects: 85
Study 33588142 — intervention group
Group type: EXPERIMENTAL
Intervention: Farmers living/working near the incinerator
Number of subjects: 85
Study 33588142 — intervention group
Group type: COMPARATOR
Intervention: Control group (not exposed)
Number of subjects: 85
Study 32087025 — intervention group
Group type: EXPERIMENTAL
Intervention: MB score (derived from presence of more than two targeted leads, age of leads, type of leads)
Number of subjects: 973
Study 32087025 — intervention group
Group type: EXPERIMENTAL
Intervention: Low MB score (threshold=1)
Number of subjects: 973
Study 32087025 — intervention group
Group type: EXPERIMENTAL
Intervention: High MB score (threshold=5)
Number of subjects: 973
Study 33615951 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily synbiotic supplement (5 g prebiotic fiber + 8 billion CFU probiotic B. lactis) with 140 mg ferrous sulfate (FeSO4) daily for 8 weeks
Number of subjects: 20
Study 33615951 — intervention group
Group type: COMPARATOR
Intervention: Placebo with 140 mg ferrous sulfate (FeSO4) daily for 8 weeks
Number of subjects: 20
Study 33320058 — intervention group
Group type: EXPERIMENTAL
Intervention: Threshold training (THR)
Number of subjects: 22
Study 33320058 — intervention group
Group type: COMPARATOR
Intervention: Polarised training (POL)
Number of subjects: 22
Study 34699693 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin plus Lipusu (LP)
Number of subjects: 490
Study 34699693 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin plus gemcitabine (GP)
Number of subjects: 490
Study 34090322 — intervention group
Group type: EXPERIMENTAL
Intervention: Basketball training (2 hours/day, 5 days a week for 8 weeks)
Number of subjects: 34
Study 32048788 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 sessions per week of acupuncture (group H)
Number of subjects: 60
Study 32048788 — intervention group
Group type: COMPARATOR
Intervention: 1 session per week of acupuncture (group L)
Number of subjects: 60
Study 32826268 — intervention group
Group type: EXPERIMENTAL
Intervention: Broad volunteer support, emphasising psychosocial and existential care and signposting tasks
Number of subjects: 801
Study 32826268 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow volunteer support, emphasising nursing care tasks
Number of subjects: 801
Study 32826268 — intervention group
Group type: COMPARATOR
Intervention: PC training
Number of subjects: 801
Study 32826268 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidimensional support
Number of subjects: 801
Study 32826268 — intervention group
Group type: EXPERIMENTAL
Intervention: Practical support
Number of subjects: 801
Study 32826268 — intervention group
Group type: EXPERIMENTAL
Intervention: Training and supervision for volunteers
Number of subjects: 801
Study 34471000 — intervention group
Group type: EXPERIMENTAL
Intervention: curcuRougeTM (newly developed highly bioavailable curcumin formulation) administered for 4 weeks
Number of subjects: 0
Study 34471000 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33050760 — intervention group
Group type: EXPERIMENTAL
Intervention: Peficitinib 100 mg/day
Number of subjects: 1052
Study 33050760 — intervention group
Group type: EXPERIMENTAL
Intervention: Peficitinib 150 mg/day
Number of subjects: 1052
Study 33050760 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1052
Study 33050760 — intervention group
Group type: EXPERIMENTAL
Intervention: Peficitinib (all doses)
Number of subjects: 1052
Study 32615614 — intervention group
Group type: EXPERIMENTAL
Intervention: Central anatomical single-bundle (SB) reconstruction
Number of subjects: 34
Study 32615614 — intervention group
Group type: COMPARATOR
Intervention: Anatomical double-bundle (DB) reconstruction
Number of subjects: 34
Study 32466776 — intervention group
Group type: EXPERIMENTAL
Intervention: Predicted propofol effect site concentration (AvgCe)
Number of subjects: 186
Study 32466776 — intervention group
Group type: COMPARATOR
Intervention: Cognitive impairment (CDR levels)
Number of subjects: 186
Study 32466776 — intervention group
Group type: COMPARATOR
Intervention: Baseline cognitive measurements (MMSE, CDR, GDS, AD biomarkers)
Number of subjects: 186
Study 36097721 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-minute video featuring a Black or White female nurse discussing mental health struggles
Number of subjects: 1402
Study 36097721 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-minute video featuring a Black or White female nurse discussing mental health struggles (booster video watched 14 days later)
Number of subjects: 1402
Study 36097721 — intervention group
Group type: COMPARATOR
Intervention: Control video unrelated to mental health
Number of subjects: 1402
Study 33434399 — intervention group
Group type: EXPERIMENTAL
Intervention: DAV132 7.5 g administered concomitantly with warfarin (5 mg) and clonazepam (1 mg)
Number of subjects: 42
Study 33434399 — intervention group
Group type: EXPERIMENTAL
Intervention: DAV132 7.5 g administered 1 hour before warfarin (5 mg) and clonazepam (1 mg)
Number of subjects: 42
Study 32967874 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated communication support program for oncologists (2.5-hour training) and patients/caregivers (half-hour coaching)
Number of subjects: 200